TCL Archive A Message From NCI: “We Deeply Regret The Need To Eliminate This Program.” AP4 Applicants And Corporate Partners Spent Years, Money, Before NCI Pulled The Plug On Novel Public-Private Partnerships. Von Eschenbach Called AP4 “A New Paradigm” For Drug Development. NCI Executive Committee “Prioritized” Programs. April 21, 2006
TCL Archive Also von Eschenbach Role in Industry Program Raises New Concerns of Conflict of Interest. November 22, 2006
TCL Archive Amgen Agrees to Settle Aranesp Marketing Lawsuit, Reserves $780 Million For Settlement October 28, 2011
